Business
Result of EGM
Result of EGM.
About this update from Ixico Plc
[{"type":"text","content":"\n RNS Number : 7892E Phytopharm PLC 29 December 2009 \n\nTHIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA OR NEW ZEALAND OR TO US PERSONS. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES. THE SECURITIES DISCUSSED HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT. NO PUBLIC OFFERING OF THE SECURITIES DISCUSSED HEREIN IS BEING MADE IN THE UNITED STATES AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFERING OF SECURITIES FOR SALE IN THE UNITED STATES, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA OR NEW ZEALAND.\n\n29 December 2009\nPhytopharm plc\n(\"Phytopharm\" or \"the Company\")\nThe Board of Phytopharm announces that at its General Meeting held on 29 December 2009 all the Resolutions were duly passed including the granting of authority to the Directors to allot shares pursuant to the Placing and Open Offer announced on 3 December 2009, and a waiver of the obligations under Rule 9 of the Takeover Code following a vote of independent shareholders. \nThe Placing and Open Offer remains conditional upon, inter alia, admission of the New Ordinary Shares to trading on the London Stock Exchange's main market and to listing on the Official List of the UK Listing Authority.\nApplication has been made to the FSA for the New Ordinary Shares to be admitted to the Official List and to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on the London Stock Exchange's main market. It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8.00 a.m. on 30 December 2009.\nIn accordance with the Takeover Code, Phytopharm announces that following Admission, Invesco will be interested in 195,527,148 shares representing 56.4% of the outstanding issued share capital of the Company following the Placing and Open Offer.\nThe proxy figures for the resolutions are set out on the Company's website www.phytopharm.com.\nAs required by the Lis...